Compare Definium Therapeutics Inc. Common Shares (DFTX) vs D R Horton Inc (DHI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs D R Horton Inc — how do they compare? Definium Therapeutics Inc. Common Shares trades at $34.01 (market cap $4.71B), while D R Horton Inc trades at $135.82 (market cap $37.28B). The key difference: D R Horton Inc is far larger — about 7.9× Definium Therapeutics Inc. Common Shares's market cap, and D R Horton Inc pays a 1.35% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and D R Horton Inc for 46 Days on average.
| DFTX | DHI | |
|---|---|---|
Market Cap | $4.71B | $37.28B |
Volume | 1,966,636 | 3,571,611 |
Sector | Health | Consumer Cyclical |
52-Week High | $48.45 | $167.78 |
52-Week Low | $10.68 | $132.53 |
Typical Hold Time | 0 Days | 46 Days |
Enterprise Value | $3.67B | $42.38B |
Dividend Yield | — | 1.35% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
D.R. Horton (DHI) trades at $135.82, down 0.68% amid broader housing sector pressure from rising mortgage rates. The stock shows bearish technical signals with oversold RSI readings, while fundamentals remain solid with consistent earnings beats and attractive valuation at 12.71 P/E. Recent news highlights sector-wide challenges as mortgage rates approach 7%, though the company maintains strong cash flow generation and dividend payments.
Despite near-term headwinds from rising rates, DHI's strong market position, consistent execution, and discounted valuation present opportunity for long-term investors. Key risks include prolonged housing market weakness and further rate hikes, but analyst consensus remains positive with $156.57 price target suggesting 15% upside potential from current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About D R Horton Inc
D.R. Horton is a leading homebuilder in the United States with operations in 98 markets across 31 states. D.R. Horton mainly builds single-family detached homes (over 90% of home sales revenue) and offers products to entry-level, move-up, luxury buyers, and active adults. The company offers homebuyers mortgage financing and title agency services through its financial services segment. D.R. Horton's headquarters are in Arlington, Texas, and it manages six regional segments across the United States.
Read more on DHI →
